Ceretype Neuromedicine

Ceretype Neuromedicine

Cambridge, United States· Est. 2021

In nearly every area of medicine, biological evidence is imperative for diagnosis and treatment of a medical condition. However, development and use of therapies for psychiatric and many neurologic disorders have not benefited from biological brain-based evidence in practice, despite many years of research, due to both scientific and platform limitations. Current practice relies on subjective reports and trial and error treatment.

Private Company

Total funding raised: $51M

About

In nearly every area of medicine, biological evidence is imperative for diagnosis and treatment of a medical condition. However, development and use of therapies for psychiatric and many neurologic disorders have not benefited from biological brain-based evidence in practice, despite many years of research, due to both scientific and platform limitations. Current practice relies on subjective reports and trial and error treatment.

Diagnostics

Funding History

1
Total raised:$51M
Series A$51MJun 15, 2023